Invest on your own
Build your own portfolio, stock by stock.
We do it for you
Professionally managed portfolios, built and rebalanced for you.
NEW
How we screen every stock
Our halal screening & purification process in 3 minutes
Screeners
Your portfolio
Calculators
TOOL
Check any stock in seconds
Search 11,000+ tickers and see the halal verdict instantly.
Our certifications
Independent proof that every stock and portfolio meets halal standards.
METHODOLOGY
How we screen every stock
Our 5-step halal methodology, in 90 seconds.
Get help
NEW
Halal investing 101
A beginner-friendly intro to investing the halal way.
Plans by product
COMPARE
Find your plan
See every feature side-by-side and pick what fits.
Investors
INVESTORS
Invest in Musaffa
We're building the financial house for 1.9B Muslims. See the deck.
NDOI Shariah Compliance
Screening Methodology: AAOIFI
NOT HALAL
Last Updated: March 24, 2025
Report Source: 2024 Annual Report
Endo Inc. Stock Analysis NDOI
United States Health Care Small Cap Report: Endo, Inc. is a pharmaceutical company, which boldly transforming insights into life-enhancing therapies. The company is headquartered in Malvern, Pennsylvania and currently employs 3,116 full-time employees. The company went IPO on 2024-06-27. The Company’s segments include Branded Pharmaceuticals, Sterile Injectables, Generic Pharmaceuticals, and International Pharmaceuticals. The Branded Pharmaceuticals segment includes a variety of branded products in the therapeutic areas of urology, orthopedics, endocrinology and bariatrics, among others. Its products include XIAFLEX, SUPPRELIN LA, AVEED, PERCOCET, TESTOPEL, and EDEX. The Sterile Injectables segment consists primarily of branded sterile injectable products, such as ADRENALIN, VASOSTRICT, APLISOL and certain generic sterile injectable products. The Generic Pharmaceuticals segment consists of solid oral extended-release products and solid oral immediate-release products. The International Pharmaceuticals segment includes a variety of specialty pharmaceutical products, including over-the-counter (OTC) products, sold outside the United States.
Read More Endo Inc (NDOI) Chart
Key Statistics of Endo Inc (NDOI)
Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.
Today's Range
Today's Open
$23.54Volume
537.00P/E Ratio (TTM)
0.3252 Week Range
Market Cap
1.80BAvg. Volume
104.74KDividend Yield
-Financial Metrics & Statements of Endo Inc (NDOI)
FAQ's for Endo Inc (NDOI)
- According to Musaffa’s Shariah screening methodology, Endo Inc (NDOI) is currently classified as NOT HALAL as of March 2025. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.
- A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Endo Inc using these criteria to determine its compliance status.
- Muslim investors may consider investing in Endo Inc if it meets Shariah compliance standards. Investors typically review the company’s business activities, debt levels, and non-permissible income before making a decision.
- Musaffa determines the Shariah status of Endo Inc by analyzing whether the company’s core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.
- The Shariah compliance status of Endo Inc may be updated periodically when new financial statements, earnings reports, or business activity information become available.
- Yes. A stock that is currently Shariah-compliant may become non-compliant if the company’s financial ratios exceed Shariah thresholds or its business activities change.
- You can check the latest Shariah compliance status of Endo Inc on Musaffa’s stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.